NASDAQ : PLRZ
Polyrizon Ltd. — Financial statements
Healthcare · Biotechnology · Israel
Last price 10.75 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 26.11M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Selling, General & Admin | 5.35M | 4.12M | 768.00K | 303.00K | 548.00K | 458.00K |
| Research & Development | 2.78M | 2.13M | 534.00K | 332.00K | 347.00K | 245.00K |
| Operating Expenses | 8.13M | 6.25M | 1.30M | 635.00K | 895.00K | 703.00K |
| Operating Income | -8.13M | -6.25M | -1.30M | -635.00K | -895.00K | -703.00K |
| Interest & Investment Income | 3.72M | 370.00K | ||||
| Currency Exchange Gain (Loss) | 7.00K | 139.00K | 4.00K | -11.00K | -26.00K | -6.00K |
| Other Non Operating Income (Expenses) | -3.22M | 2.00M | -239.00K | 63.00K | 142.00K | -2.00K |
| EBT Excluding Unusual Items | -7.62M | -3.74M | -1.54M | -583.00K | -779.00K | -711.00K |
| Gain (Loss) on Sale of Investments | 3.00M | 404.00K | -8.00K | -17.00K | ||
| Pretax Income | -4.58M | -3.33M | -1.54M | -600.00K | -779.00K | -711.00K |
| Net Income | -4.58M | -3.33M | -1.54M | -600.00K | -779.00K | -711.00K |
| Preferred Dividends & Other Adjustments | 60.00K | 69.00K | 44.00K | 44.00K | ||
| Net Income to Common | -4.58M | -3.33M | -1.60M | -669.00K | -823.00K | -755.00K |
| Shares Outstanding (Basic) | 1.46M | 680.38K | ||||
| Shares Outstanding (Diluted) | 1.46M | 680.38K | ||||
| EPS (Basic) | -3.13 | -4.90 | ||||
| EPS (Diluted) | -3.13 | -4.90 | ||||
| Free Cash Flow | -4.67M | -4.54M | -1.15M | -537.00K | -1.14M | -511.00K |
| Free Cash Flow Per Share | -3.19 | -6.67 | ||||
| EBITDA | -7.82M | -5.91M | -1.18M | -631.00K | -890.00K | -697.00K |
| D&A For EBITDA | 306.00K | 342.00K | 118.00K | 4.00K | 5.00K | 6.00K |
| EBIT | -8.13M | -6.25M | -1.30M | -635.00K | -895.00K | -703.00K |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 8.41M | 1.31M | 2.55M | 4.00K | 36.00K | 523.00K |
| Short-Term Investments | 4.05M | 10.38M | ||||
| Trading Asset Securities | 3.61M | 783.00K | 37.00K | |||
| Cash & Short-Term Investments | 16.07M | 12.46M | 2.55M | 41.00K | 36.00K | 523.00K |
| Prepaid Expenses | 223.00K | 4.00K | ||||
| Other Current Assets | 222.00K | 173.00K | 95.00K | 13.00K | 15.00K | 21.00K |
| Total Current Assets | 16.29M | 12.86M | 2.65M | 54.00K | 51.00K | 544.00K |
| Property, Plant & Equipment | 12.00K | 12.00K | 10.00K | 12.00K | 16.00K | 18.00K |
| Long-Term Investments | 6.16M | 6.02M | ||||
| Other Intangible Assets | 2.40M | 2.55M | 2.88M | |||
| Long-Term Deferred Charges | 493.00K | 479.00K | 125.00K | |||
| Total Assets | 24.86M | 21.44M | 5.55M | 559.00K | 546.00K | 687.00K |
| Accrued Expenses | 59.00K | 149.00K | 45.00K | 39.00K | 178.00K | 174.00K |
| Short-Term Debt | 200.00K | 622.00K | ||||
| Other Current Liabilities | 389.00K | 294.00K | 216.00K | 263.00K | 398.00K | 516.00K |
| Total Current Liabilities | 448.00K | 443.00K | 261.00K | 502.00K | 1.20M | 690.00K |
| Total Liabilities | 448.00K | 443.00K | 261.00K | 502.00K | 1.20M | 690.00K |
| Additional Paid-In Capital | 34.24M | 29.39M | 10.35M | 3.53M | 2.02M | 1.89M |
| Retained Earnings | -9.82M | -8.40M | -5.07M | -3.72M | -2.92M | -2.14M |
| Total Common Equity | 24.41M | 20.99M | 5.29M | -191.00K | -900.00K | -251.00K |
| Shareholders' Equity | 24.41M | 20.99M | 5.29M | 57.00K | -652.00K | -3.00K |
| Total Liabilities & Equity | 24.86M | 21.44M | 5.55M | 559.00K | 546.00K | 687.00K |
| Total Debt | 200.00K | 622.00K | ||||
| Net Cash (Debt) | 16.07M | 12.46M | 2.55M | -159.00K | -586.00K | 523.00K |
| Net Cash Per Share | 10.97 | 18.32 | ||||
| Filing Date Shares Outstanding | 2.13M | 1.62M | ||||
| Total Common Shares Outstanding | 2.13M | 1.61M | ||||
| Working Capital | 15.85M | 12.42M | 2.39M | -448.00K | -1.15M | -146.00K |
| Book Value Per Share | 11.49 | 13.05 | ||||
| Tangible Book Value | 22.02M | 18.45M | 2.40M | -191.00K | -900.00K | -251.00K |
| Tangible Book Value Per Share | 10.36 | 11.47 |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -4.58M | -3.33M | -1.54M | -600.00K | -779.00K | -711.00K |
| Depreciation & Amortization | 306.00K | 342.00K | 118.00K | 4.00K | 5.00K | 6.00K |
| Loss (Gain) From Sale of Investments | -2.59M | 8.00K | 17.00K | |||
| Stock-Based Compensation | 2.63M | 1.31M | 51.00K | 100.00K | 130.00K | 184.00K |
| Other Operating Activities | -514.00K | -2.69M | 242.00K | -65.00K | -144.00K | |
| Change in Other Net Operating Assets | 93.00K | -158.00K | -21.00K | 7.00K | -344.00K | 29.00K |
| Operating Cash Flow | -4.66M | -4.53M | -1.15M | -537.00K | -1.13M | -492.00K |
| Capital Expenditures | -8.00K | -7.00K | -3.00K | -19.00K | ||
| Investment in Securities | -10.59M | -16.53M | 29.00K | |||
| Investing Cash Flow | -10.60M | -16.53M | 29.00K | -3.00K | -19.00K | |
| Short-Term Debt Issued | 310.00K | 249.00K | 648.00K | |||
| Total Debt Issued | 310.00K | 249.00K | 648.00K | |||
| Short-Term Debt Repaid | -316.00K | |||||
| Total Debt Repaid | -316.00K | |||||
| Net Debt Issued (Repaid) | -6.00K | 249.00K | 648.00K | |||
| Issuance of Common Stock | 7.84M | 19.81M | 3.67M | 256.00K | 1.02M | |
| Financing Cash Flow | 7.84M | 19.81M | 3.67M | 505.00K | 648.00K | 1.02M |
| Net Cash Flow | -7.42M | -1.25M | 2.55M | -32.00K | -487.00K | 513.00K |
| Free Cash Flow | -4.67M | -4.54M | -1.15M | -537.00K | -1.14M | -511.00K |
| Free Cash Flow Per Share | -3.19 | -6.67 | ||||
| Levered Free Cash Flow | -2.09M | -2.38M | -771.75K | -564.88K | -535.38K | 401.62K |
| Unlevered Free Cash Flow | -2.09M | -2.38M | -771.75K | -564.88K | -535.38K | 401.62K |
| Change in Working Capital | 93.00K | -158.00K | -21.00K | 7.00K | -344.00K | 29.00K |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 27.35M | 13.53M | 9.10M | |||
| Enterprise Value | 11.27M | -2.30M | 9.48M | |||
| Last Close Price | 11.26 | 8.49 | 3,255.00 | |||
| PB Ratio | 0.98 | 0.65 | 1.72 | |||
| P/TBV Ratio | 1.24 | 0.73 | 3.79 | |||
| Debt / Equity Ratio | 3.51 | -0.95 | ||||
| Net Debt / Equity Ratio | -0.66 | -0.59 | -0.48 | 2.79 | -0.90 | 174.33 |
| Net Debt / EBITDA Ratio | 2.06 | 2.11 | 2.16 | -0.25 | -0.66 | 0.75 |
| Net Debt / FCF Ratio | 3.44 | 2.75 | 2.23 | -0.30 | -0.52 | 1.02 |
| Quick Ratio | 35.88 | 28.14 | 9.79 | 0.08 | 0.03 | 0.76 |
| Current Ratio | 36.37 | 29.03 | 10.16 | 0.11 | 0.04 | 0.79 |
| Return on Equity (ROE) | -21.42% | -25.38% | -57.83% | -10,938.46% | ||
| Return on Assets (ROA) | -23.30% | -28.95% | -26.65% | -71.83% | -90.73% | -123.59% |
| Return on Capital Employed (ROCE) | -33.30% | -29.80% | -24.60% | -1,114.00% | 137.30% | 23,433.30% |
| Earnings Yield | -27.78% | -24.64% | -16.98% | |||
| FCF Yield | -17.08% | -33.51% | -12.60% |